Finanzen von Cybin Inc (HELP)HELPCybin Inc

In the context of the broader market, HELP competes directly with industry leaders such as KAPA and OGEN. With a market capitalization of $767.13M, it holds a leading position in the sector. When comparing efficiency, HELP's gross margin of N/A stands against KAPA's N/A and OGEN's N/A. Such benchmarking helps identify whether Helus Pharma Inc. is trading at a premium or discount relative to its financial performance.

The company has reported increasing net losses, with the latest quarterly net income at -$46,995,000 and an EPS of -0.91, indicating financial struggles.